Association of bladder cancer risk with an NAD(P)H: Quinone oxidoreductase polymorphism in an ethnic kashmiri population

Biochemical Genetics

Volumn 49, Issue 7-8, 2011, Pages 417-426

  Pandith, Arshad A ^a   Khan, Nighat P ^a   Shah, Zafar A ^a   Shah, Amin M ^a   Wani, Saleem M ^a   Siddiqi, Mushtaq A ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bladder cancer; Kashmiri; NQO1; Polymorphism; Quinone oxidoreductase

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; KASHMIRI; MAJOR CLINICAL STUDY; MALE; NAD(P)H QUINONE OXIDOREDUCTASE GENE; POPULATION BASED CASE CONTROL STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; ALLELES; CASE-CONTROL STUDIES; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 79960844329     PISSN: 00062928     EISSN: 15734927     Source Type: Journal    
DOI: 10.1007/s10528-011-9418-8     Document Type: Article

References (44)

1. AP Arshad S Zafar R Roohi Dil-Afroze Y Adfar P Nighat W Saleem Siddiqi Mushtaq 2010 Activated H-ras gene mutations in transitional cell carcinoma of urinary bladder in a Kashmiri population Tumori 96 993 998
2. G Asher J Lotem B Cohen L Sachs Y Shaul 2001 Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1 Proc Natl Acad Sci USA 89 1188 1193 10.1073/pnas.021558898 (Pubitemid 32121208)
3. G Asher J Lotem L Sachs C Kahana Y Shaul 2002 Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1 Proc Natl Acad Sci USA 99 13125 13130 12232053 10.1073/pnas.202480499 1:CAS:528: DC%2BD38XnvFGhurk%3D
4. A Begleiter E Robotham G Lacey MK Leith 1989 Increased sensitivity of quinone resistant cells to mitomycin C Cancer Lett 45 173 176 2471583 10.1016/0304-3835(89)90073-6 1:CAS:528:DyaL1MXkslSnurw%3D (Pubitemid 19148580)
5. A Begleiter MK Leith TJ Curphey GP Doherty 1997 Induction of DT-diaphorase in cancer chemoprevention and chemotherapy Oncol Res 9 371 382 9406243 1:CAS:528:DyaK1cXhsVGgs7w%3D (Pubitemid 127825991)
6. J Brockmoller I Cascorbi S Henning C Meisel I Roots 2000 Molecular genetics of cancer susceptibility Pharmacology 61 212 227 10971208 10.1159/000028403 1:CAS:528:DC%2BD3cXntlCgtr0%3D
7. C Chao ZF Zhang J Berthiller P Boffetta M Hashibe 2006 NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis Cancer Epidemiol Biomarkers Prev 15 979 987 16702380 10.1158/1055-9965.EPI-05-0899 1:CAS:528:DC%2BD28XksFeiu7s%3D (Pubitemid 43823527)
8. H Chen A Lum A Seifried LR Wilkens L Le Marchand 1999 Association of the NAD (P)H:quinone oxidoreductase 609C→T polymorphism with a decreased lung cancer risk Cancer Res 59 3045 3048 10397241 1:CAS:528:DyaK1MXksVCksr8%3D (Pubitemid 29315998)
9. JY Choi KM Lee SH Cho SW Kim HY Choi SY Lee HJ Im KJ Yoon H Choi I Choi A Hirvonen RB Hayes D Kang 2003 CYP2E1 and NQO1 genotypes, smoking and bladder cancer Pharmacogenetics 13 349 355 12777965 10.1097/00008571-200306000-00006 1:CAS:528:DC%2BD3sXktlyku7o%3D (Pubitemid 36724528)
10. GA Choudry PA Hamilton Stewart JA Double MRL Krul B Naylor GM Flannigan TK Shah JE Brown RM Philips 2001 A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9 Br J Cancer 85 1137 1146 11710826 10.1054/bjoc.2001.2056 1:CAS:528:DC%2BD3MXoslamu7o%3D (Pubitemid 33052312)
11. DB Clayson 1981 Specific aromatic amines as occupational bladder carcinogens Natl Cancer Inst Monogr 58 15 19 7341971
12. S Costa D Pinto D Pereira H Rodrigues J Cameselle-Teijeiro R Medeiros F Schmitt 2008 Importance of TP53 codon 72 and intron 3 duplication 16 bp polymorphisms in prediction of susceptibility on breast cancer BMC Cancer 8 32 18230179 10.1186/1471-2407-8-32 (Pubitemid 351314953)
13. MJ Droller 1998 Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines J Urol 160 618 9679939 10.1016/S0022-5347(01)62227-4 1:STN:280:DyaK1czktlGgsQ%3D%3D
14. P Eickelmann WA Schulz D Rohde B Schmitz-Drager H Sies 1994 Loss of heterozygosity at the NAD(P)H:quinine oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line Biol Chem Hoppe Seyler 375 439 445 7945992 10.1515/bchm3.1994.375.7.439 1:CAS:528:DyaK2cXmt1OmtLo%3D (Pubitemid 2120331)
15. L Ernster 1987 DT diaphorase: a historical review Chem Scr 27A 1 13 1:CAS:528:DyaL1cXltFKrsA%3D%3D
16. EC Friedberg 2003 DNA damage and repair Nature 421 436 440 12540918 10.1038/nature01408 (Pubitemid 36157951)
17. N Hamajima K Matsuo H Iwata M Shinoda Y Yamamura T Kato S Hatooka T Mitsudomi M Suyama Y Kagami M Ogura M Ando Y Sugimura K Tajima 2002 NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese Int J Clin Oncol 7 103 108 12018106 1:CAS:528: DC%2BD38XktFWksLc%3D (Pubitemid 34538454)
18. LE Johns RS Houlston 2000 Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: a meta-analysis Mutagenesis 15 399 404 10970445 10.1093/mutage/15.5.399 1:CAS:528:DC%2BD3cXmvFSnt7o%3D
19. LE Johns RS Houlston 2000 N-acetyl transferase-2 and bladder cancer risk: a meta-analysis Environ Mol Mutagen 36 221 227 11044903 10.1002/1098-2280(2000) 36:3<221::AID-EM5>3.0.CO;2-Q 1:CAS:528:DC%2BD3cXnvVGgsbo%3D
20. P Joseph AK Jaiswal 1994 NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase Proc Natl Acad Sci USA 91 8413 8417 8078896 10.1073/pnas.91.18.8413 1:CAS:528:DyaK2cXlslarsrg%3D (Pubitemid 24273674)
21. KT Kelsey D Ross RD Traver DC Christiani ZF Zuo MR Spitz M Wang X Xu BK Lee BS Schwartz JK Wiencke 1997 Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy Br J Cancer 76 852 854 9328142 10.1038/bjc.1997.474 1:CAS:528:DyaK2sXmvVGqtb4%3D (Pubitemid 27401934)
22. BL Kuehl JW Paterson JW Peacock MC Paterson AM Rauth 1995 Presence of a heterozygous substitution and its relationship to DT-diaphorase activity Br J Cancer 72 555 561 7669561 10.1038/bjc.1995.373 1:CAS:528:DyaK2MXotV2kt7w%3D
23. RA Larson Y Wang M Banerjee J Wiemels C Hartford MM Le Beau MT Smith 1999 Prevalence of the inactivating 609C3T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy related myeloid leukemia Blood 94 803 807 10397748 1:CAS:528:DyaK1MXksVemu7o%3D (Pubitemid 29323895)
24. SJ Lewis NM Cherry RM Niven PV Barber AC Povey 2001 Polymorphisms in the NAD(P)H:quinone oxidoreductase gene and small cell lung cancer risk in a UK population Lung Cancer 34 177 183 11679176 10.1016/S0169-5002(01)00243-4 1:STN:280:DC%2BD3Mrnt1WhsQ%3D%3D (Pubitemid 33010793)
25. DJ Long II A Gaikwad A Multani S Pathak CA Montgomery FJ Gonzalez AK Jaiswal 2002 Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) Cancer Res 62 3030 3036 12036909 1:CAS:528:DC%2BD38XksVyru7o%3D
26. H-J Menze J Sarmanova P Soucek R Berberich K Grunewald M Haun HG Kraft 2004 Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations Br J Cancer 90 1989 1994 10.1038/sj.bjc.6601779 (Pubitemid 38746342)
27. V Misra A Grondin HJ Klamut AM Rauth 2000 Assessment of the relationship between genotypic status of a DT-diaphorase point mutation and enzymatic activity Br J Cancer 83 998 1002 10993645 10.1054/bjoc.2000.1359 1:CAS:528:DC%2BD3cXnsF2hs78%3D
28. PN Mitrou MA Watson AS Loktionov AS Cardwell 2007 Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS study Carcinogenesis 28 875 882 17082176 10.1093/carcin/bgl194 1:CAS:528:DC%2BD2sXjslOnsbw%3D (Pubitemid 46523343)
29. SJ Park H Zhao MR Spitz HB Grossman X Wu 2003 An association between NQO1 genetic polymorphism and risk of bladder cancer Mutat Res 536 131 137 12694753 1:CAS:528:DC%2BD3sXivFGisb8%3D (Pubitemid 36411663)
30. M Peluso L Airoldi C Magagnotti L Fiorini A Munnia A Hautefeuille C Malaveille P Vineis 2000 White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer Carcinogenesis 21 183 187 10657956 10.1093/carcin/21.2.183 1:CAS:528:DC%2BD3cXhs1Sjtbg%3D (Pubitemid 30098701)
31. M Ploeg KHA Katja AK Lambertus 2009 The present and future burden of urinary bladder cancer in the world World J Urol 27 289 293 19219610 10.1007/s00345-009-0383-3
32. HJ Prochaska P Talalay H Sies 1987 Direct protective effect of NAD(P)H:quinone reductase against menadione-induced chemiluminescence of postmitochondrial fractions of mouse liver J Biol Chem 262 5 1931 1934 2434474 1:CAS:528:DyaL2sXhtlWgur0%3D
33. JH Rayjean P Paolo B Paul M Christian G Umberto P Donatella C Angela H Agnes P Stefano 2004 Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk Carcinogenesis 25 6 973 978 10.1093/carcin/bgh080 (Pubitemid 38886083)
34. D Ross D Siegel H Beall AS Prakash RT Mulcahy NW Gibson 1993 DT-diaphorase in activation and detoxification of quinones: Bioreductive activation of mitomycin C Cancer Metastasis Rev 12 83 101 8375023 10.1007/BF00689803 1:CAS:528:DyaK2cXksVymtw%3D%3D (Pubitemid 23220674)
35. M Sarbia M Bitzer D Siegel D Ross WA Schulz RB Zotz S Kiel H Geddert 2003 Association between NAD(P)H:quinine oxidoreductase 1 (NQO1) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract Int J Cancer 107 3 381 386 14506737 10.1002/ijc.11430 1:CAS:528:DC%2BD3sXos1Gns7s%3D (Pubitemid 37266457)
36. WA Schulz A Krummeck I Rosinger P Eickelmann C Neuhaus T Ebert BJ Schmitz Drager H Sies 1997 Increased frequency of a null allele for NAD(P)H:quinone oxidoreductase in patients with urological malignancies Pharmacogenetics 7 235 239 9241663 10.1097/00008571-199706000-00008 1:CAS:528:DyaK2sXkvFymtb8%3D (Pubitemid 27290637)
37. D Siegel SM McGuinness SL Winski D Ross 1999 Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase Pharmacogenetics 9 113 121 10208650 10.1097/00008571-199902000-00015 1:CAS:528:DyaK1MXjtlyqsb8%3D (Pubitemid 29176730)
38. Siegel D, Anwar A, Winski S, Kepa JK, Ross D (2000) The NQO1*2 polymorphism in NAD(P)H:quinine oxidoreductases 1 targets the protein for proteasomal degradation. Proc Am Assoc Cancer Res 227
39. N Sunaga T Kohno N Yanagitani H Sugimura H Kunitoh T Tamura Y Takei S Tsuchiya R Saito J Yokota 2002 Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility Cancer Epidemiol Biomarkers Prev 11 730 738 12163326 1:CAS:528:DC%2BD38XmvVaqsLs%3D (Pubitemid 34851907)
40. RD Traver D Siegel HD Beall RM Phillips NW Gibson WA Franklin D Ross 1997 Characterization of a polymorphism in NAD(P)H:quinone oxidoreductase (DT diaphorase) Br J Cancer 75 69 75 9000600 10.1038/bjc.1997.11 1:CAS:528:DyaK2sXmsF2gsw%3D%3D (Pubitemid 27007275)
41. JK Wiencke MR Spitz A McMillan KT Kelsey 1997 Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H:quinone oxidoreductase polymorphism Cancer Epidemiol Biomarkers Prev 6 87 92 9037558 1:STN:280:DyaK2s7ovFejsg%3D%3D (Pubitemid 27069200)
42. L Yin Y Pu T Liu T Tung K Chen P Lin 2001 Genetic polymorphisms of NAD(P)H:quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China Lung Cancer 33 133 141 11551408 10.1016/S0169-5002(01)00182-9 1:STN:280:DC%2BD3MrgtF2guw%3D%3D (Pubitemid 32707894)
43. MP Zeegers E Kellen F Buntinx PA van den Brandt 2004 The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review World J Urol 21 392 401 14685762 10.1007/s00345-003-0382-8
44. J-H Zhang Y Li R Wang W Guo N Wang DG Wen ZF Chen G Kuang LZ Wei SJ Wang 2003 NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China World J Gastroenterol 9 1390 1393 12854127 1:CAS:528:DC%2BD3sXoslajtr8%3D (Pubitemid 36992319)